Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Contact information

Email
Daniel.Jenkin@ndm.ox.ac.uk

ORCID
https://orcid.org/0000-0003-3088-310X

Research groups

Daniel Jenkin

MBChB, MSc, DTM&H, MRCP

Clinical Research Fellow

Websites

Research Gate Profile

Recent publications

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Journal article

Barrett JR. et al, (2021), Nature Medicine
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Journal article

Emary KRW. et al, (2021), The Lancet, 397, 1351 - 1362
Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Journal article

Folegatti PM. et al, (2021), Vaccines, 9, 262 - 262
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Journal article

Voysey M. et al, (2021), The Lancet, 397, 881 - 891
Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)
Journal article

Emary KRW. et al, (2021), SSRN Electronic Journal

More publications